Taixing is accelerating the deep integration of scientific and industrial innovation, shifting its core strategy from building platforms to generating tangible results.
Taixing in Taizhou, Jiangsu province, has expanded its high-level innovation platform with the addition of two national-level postdoctoral research stations, approved by the Ministry of Human Resources and Social Security.
Taixing's biopharmaceutical sector has achieved a significant milestone. Space Peptides Pharmaceutical (Taizhou) recently secured Drug Master File filing with the U.S. Food and Drug Administration for its semaglutide active pharmaceutical ingredient.
Reaching 180 million yuan ($26.88 million) in annual sales by 2025, Taizhou Yuyue Packaging Materials has completed a remarkable 12-year evolution from a small township processor into a national high-tech enterprise.
Twenty-three Taixing enterprises have been named to Jiangsu province's 2026 advanced smart factory list, signaling a major step forward in the digital transformation of the city's manufacturing industry.
The Taixing Economic Development Zone is staking its claim in China's booming low-altitude economy, channeling its smart manufacturing strengths into drone development, pilot training and aviation services.
